REGN
REGN
NASDAQ · Biotechnology

Regeneron Pharmaceuticals

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$803.90
+5.73 (+0.72%)
As of Sep 22, 9:33 PM ET ·
Analyst Consensus
Buy
38
Analysts
Very High
Coverage
Buy 26 68%
Hold 12 32%
Sell 0 0%
Price Target
Analyst Price Target -90.4% upside
Low Target $61.79
Average Target $76.80
High Target $111.17
Current Price $803.90
Current
$803.90
Target
$76.80
$61.79 $76.80 avg $111.17
Scenario Analysis
Bear Case
$61.79
-92.3%
Low target
Base Case
$76.80
-90.4%
Avg target
Bull Case
$111.17
+-86.2%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$859.34
-6.5% from high
52-Week Low
$541.00
+48.6% from low
50-Day SMA
$763.91
+5.2% vs SMA
200-Day SMA
$631.14
+27.4% vs SMA
RSI (14)
59.8
Neutral
Target vs 52W High
$76.80
-91.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%